Taylor Boyd

Taylor Boyd

Chief Business OfficeratAvalo Therapeutics· In proxies 2024–2025

Pay in FY2025Avalo Therapeutics stock +144.4% the same year

Taylor Boyd was paid $3.2M in FY2025 (Dec). Avalo Therapeutics stock rose 144.4% that year.

Pay$100 in the stock at the end of FY23 → $200
Pay is from the Summary Compensation Table of each Avalo Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Avalo TherapeuticsPublic company · 2 yr
    • Chief Business Officer2024 – Present · 2 yrStock in role -43%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?